2707433-64-3
2707433-64-3
Chemical Structure
Famotidine-d4
Synonym(s): MK-208-d4
- CAS No.: 2707433-64-3
- Formula:C8H11D4N7O2S3
- Molecular Weight:341.47
InChIKey: XUFQPHANEAPEMJ-LNLMKGTHSA-N
SMILES: NS(/N=C(C([2H])(C([2H])(SCC1=CSC(/N=C(N)\N)=N1)[2H])[2H])\N)(=O)=O
Biological Activity: Famotidine-d4 (MK-208-d4) is deuterium labeled Famotidine. Famotidine (MK-208) is a competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Famotidine-d4 | Famotidine-d4 (MK-208-d4) is deuterium labeled Famotidine. Famotidine (MK-208) is a competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Famotidine (Standard) | 99.93% | Famotidine (Standard) is the analytical standard of Famotidine. This product is intended for research and analytical applications. Famotidine (MK-208) is a competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Famotidine-13C3 | Famotidine-13C3 (MK-208-13C3) is the 13C-labeled Famotidine (HY-B0377). Famotidine (MK-208) is a competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Famotidine-13C | Famotidine-13C (MK-208-13C) is 13C labeled Famotidine. Famotidine (MK-208) is a competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Famotidine-13C,d3 | Famotidine-13C,d3 is the 13C- and deuterium labeled Famotidine. Famotidine (MK-208) is a competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Famotidine (GMP) | Famotidine GMP (MK-208 GMP) is Famotidine (HY-B0377) produced in GMP guideline. Famotidine GMP is a competitive histamine H2-receptor antagonist, inhibits gastric secretion, activates the gastric mucosal defensive mechanisms. Famotidine GMP ameliorates peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD/GORD) in rats model. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Famotidine | 99.85% | Famotidine (MK-208) is a competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
